Latest Breaking News On - Matthew lunning - Page 2 : comparemela.com

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

Drs Lunning and Mehta-Shah highlight challenges that arise when diagnosing patients with peripheral T-cell lymphoma and how molecular testing results influence induction and consolidation treatment approaches for patients with ALK-negative anaplastic large cell lymphoma.

United statesWashington universityMatthew lunningNeha mehta shahUniversity of nebraska medical centerDepartment of internal medicineBlood clubDivision of oncology hematologyInternal medicineNebraska medical centerWashington university schoolUniversity of nebraska medical centerPatients with peripheralt cell lymphomaWashington university school of medicine

Lunning and Jacobson Dissect the Role of CAR T-Cell Therapy in Follicular Lymphoma

Drs Lunning and Jacobson discuss the characteristics of follicular lymphoma that may prompt aggressive treatment, the potential optimal role of CAR T-cell therapy in the third line and beyond, and how the toxicity profiles of different CAR T-cell products compare with each other.

Dana farber cancer instituteUnited statesCarona jacobsonMatthew lunningEffector cell therapy programUniversity of nebraska medical centerHarvard medical schoolDepartment of internal medicineDivision of oncology hematologyBlood clubInternal medicineNebraska medical centerImmune effector cell therapy programFollicular lymphomaThe university of nebraska medical center

Standards of Care and Novel Therapies Converge to Propel Advances in Follicular Lymphoma

Christopher R. Flowers, MD, MS, and colleagues shed light on recent updates in the treatment armamentarium for follicular lymphoma and highlight ongoing investigations of novel agents and combinations.

United statesSameh gaballaVickia morrisonDai chiharaNathan fowlerMatthew lunningNiravn shahLymphomes folliculairesHun ju leeUniversity of nebraska medical centerUniversity of minnesotaMoffitt cancer centerDivision of cancer medicineCollege of wisconsinUniversity of texas md anderson cancer centerDepartment of lymphoma

Dr Lunning on Treatment Considerations for Relapsed/Refractory Follicular Lymphoma

Dr Lunning on Treatment Considerations for Relapsed/Refractory Follicular Lymphoma
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Matthew lunningUniversity of nebraska medical centerDivision of oncology hematologyDepartment of internal medicineClinical researchInternal medicineNebraska medical center

Relapsed/Refractory Follicular Lymphoma: Future Directions in Care

Key opinion leaders Sameh Gaballa, MD, and Matthew Lunning, DO, FACP, consider the evolving treatment landscape of follicular lymphoma and look toward future evolutions in the field.

Matthew lunningSameh gaballaTreatment approachExpanding treatment optionsRefractory follicular lymphomaFuture directionsFollicular lymphomaRelapsed refractory flRelapsed refractory follicular lymphomaFl cancerBispecific therapyBispecific antibodiesNovel therapyCombination therapyClinical trials